Furuta Milano 4

4 · TAKEDA PHARMACEUTICAL CO LTD · Filed Jul 6, 2026

AI-generated summary of this filing

Updated Jul 6, 2026

Takeda (TAK) CFO Furuta Milano Sells Shares

What Happened

Furuta Milano, Chief Financial Officer of Takeda Pharmaceutical (TAK), had a disposition to the issuer on July 10, 2026 of 16,619 shares (reported as a derivative transaction) for total proceeds of $81,956,599. The weighted-average price reported was JPY 4,931.50 (sales ranged JPY 4,882–5,050).
On July 1, 2026 Milano was granted awards (reported as acquisitions at $0.00) totaling 25,164 restricted stock units (RSUs): 12,300 RSUs plus three grants of 4,288 RSUs. The RSUs vest in three equal annual installments beginning June 1, 2027.
Footnotes indicate the July 10 disposition relates to Tax Obligation Awards — economic equivalents of shares that are converted to cash primarily to cover tax obligations; any remaining proceeds were to be delivered to the reporting person on July 10.

Key Details

Transaction dates: RSU grants on 2026-07-01; disposition to issuer on 2026-07-10.
Sale details: 16,619 shares disposed; weighted-average price JPY 4,931.50; proceeds $81,956,599. Reported sale prices ranged JPY 4,882–5,050; reporting person can provide a breakdown by price on request (footnote).
Grants: 25,164 RSUs awarded on 2026-07-01; vest in three equal annual installments beginning 2027-06-01 (footnote F1).
Nature of transactions: Disposition listed as “Derivative” and described in footnotes as Tax Obligation Awards converted to cash primarily to cover tax liabilities (footnotes F2, F4).
Shares owned after transaction: Not specified in the provided filing excerpt.
Filing timeliness: Filing dated 2026-07-06; no indication in the supplied data that this filing was late.

Context

This filing appears to record standard equity compensation (RSU grants) and a cash settlement/disposition tied to tax withholding (common when RSUs vest). Such tax-related dispositions are routine and do not necessarily indicate a change in insider sentiment.

Form 4

Period: 2026-07-01

DirectorChief Financial Officer

Transactions

Award
Ordinary Shares
[F1]
2026-07-01+12,300→ 70,200 total
Disposition to Issuer
Tax Obligation Award
[F2][F3]
2026-07-10$4931.50/sh−16,619$81,956,599→ 0 total
From: 2026-06-01Exp: 2026-06-01→ Ordinary Shares (16,619 underlying)
Award
Tax Obligation Award
[F4]
2026-07-01+4,288→ 11,741 total
From: 2027-06-01Exp: 2027-06-01→ Ordinary Shares (4,288 underlying)
Award
Tax Obligation Award
[F4]
2026-07-01+4,288→ 8,482 total
From: 2028-06-01Exp: 2028-06-01→ Ordinary Shares (4,288 underlying)
Award
Tax Obligation Award
[F4]
2026-07-01+4,288→ 4,288 total
From: 2029-06-01Exp: 2029-06-01→ Ordinary Shares (4,288 underlying)

Footnotes (4)

[F1]Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest in three equal annual installments beginning on June 1, 2027.
[F2]Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10.
[F3]The price reported in Column 8 is a weighted average price denominated in Yen. These shares were sold in transactions at prices ranging from JPY 4,882 to JPY 5,050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
[F4]Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.

Signature

/s/ Samuel Ntonme, by power of attorney, for Milano Furuta|2026-07-06

1 file